The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury. - Bagshaw,S.M.; Gibney,R.T.; McAlister,F.A.; Bellomo,R. (Trials, 2010)